Skip to main content
. Author manuscript; available in PMC: 2013 Dec 9.
Published in final edited form as: Cancer Res. 2012 Sep 7;72(22):10.1158/0008-5472.CAN-12-1097. doi: 10.1158/0008-5472.CAN-12-1097

Figure 3.

Figure 3

Survival prognosis of a mouse CAF-secretory gene signature in human NSCLC. A and B. Kaplan Meier plots of NSCLC patients from two different data sets, Dana Farber Cancer Institute (CAN/DF) and University of Michigan (UM), using high and low levels of a secretory gene signature corresponding to 15 secretome genes identified in mouse CAFs.